tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CRVO Stock Latest News

CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Press ReleasesCervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates
23m ago
CRVO
CervoMed files to sell 5.06M shraes of common stock for holders
PremiumThe Fly
CervoMed files to sell 5.06M shraes of common stock for holders
5d ago
CRVO
CervoMed Updates Stakeholders on Clinical and Financial Status
PremiumCompany Announcements
CervoMed Updates Stakeholders on Clinical and Financial Status
22d ago
8K
CRVO
CervoMed price target raised to $65 from $50 at Canaccord
PremiumThe Fly
CervoMed price target raised to $65 from $50 at Canaccord
1M ago
CRVO
CervoMed Shares Operational and Financial Insights Online
PremiumCompany Announcements
CervoMed Shares Operational and Financial Insights Online
1M ago
8K
CRVO
CervoMed reports FY23 EPS (82c) vs ($11.20) last year
PremiumThe FlyCervoMed reports FY23 EPS (82c) vs ($11.20) last year
1M ago
CRVO
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
PremiumPress Releases
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
1M ago
CRVO
Cervomed Inc. Braces for Impact: How Political Uncertainty and the Presidential Election Could Shake Up the Pharma Industry
PremiumCompany Announcements
Cervomed Inc. Braces for Impact: How Political Uncertainty and the Presidential Election Could Shake Up the Pharma Industry
2M ago
CRVO
CervoMed’s Strategic $50 Million Private Placement Deal
PremiumCompany Announcements
CervoMed’s Strategic $50 Million Private Placement Deal
2M ago
8K
CRVO
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
PremiumPress Releases
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
2M ago
CRVO
CervoMed announces private placement financing of up to $149.4M
PremiumThe Fly
CervoMed announces private placement financing of up to $149.4M
2M ago
CRVO
CervoMed Updates Investors on Clinical and Financial Health
PremiumCompany Announcements
CervoMed Updates Investors on Clinical and Financial Health
2M ago
8K
CRVO
CervoMed announces presentation of data from AscenD-LB Phase 2a trial
PremiumThe FlyCervoMed announces presentation of data from AscenD-LB Phase 2a trial
2M ago
CRVO
CervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024
PremiumPress Releases
CervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024
2M ago
CRVO
CervoMed to Participate in the BIO CEO and Investor Conference
PremiumPress Releases
CervoMed to Participate in the BIO CEO and Investor Conference
3M ago
CRVO
CervoMed initiated with a Buy at Canaccord
PremiumThe Fly
CervoMed initiated with a Buy at Canaccord
3M ago
CRVO
CervoMed announces data from AscenD-LB phase 2a trial
PremiumThe Fly
CervoMed announces data from AscenD-LB phase 2a trial
3M ago
CRVO
CervoMed Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal that Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy Bodies
PremiumPress Releases
CervoMed Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal that Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy Bodies
3M ago
CRVO
CervoMed Appoints New Chair and Presents at Conference 67
PremiumCompany Announcements
CervoMed Appoints New Chair and Presents at Conference 67
3M ago
8K
CRVO
CervoMed Names Joshua Boger as New Board Chair
PremiumCompany AnnouncementsCervoMed Names Joshua Boger as New Board Chair
3M ago
8K
CRVO
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
PremiumPress Releases
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
3M ago
CRVO
CervoMed appoints Joshua Boger as chair of the board
PremiumThe Fly
CervoMed appoints Joshua Boger as chair of the board
3M ago
CRVO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >